Share on StockTwits

WebMD Health Corp. (NASDAQ:WBMD) updated its fourth quarter earnings guidance on Monday. The company provided earnings per share guidance of $0.23-0.25 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.29, Stock Ratings reports. The company issued revenue guidance of $145.5-146.5 million, compared to the consensus revenue estimate of $144.01 million.

WBMD has been the subject of a number of recent research reports. Analysts at S&P Equity Research downgraded shares of WebMD Health Corp. to a sell rating in a research note to investors on Wednesday, January 22nd. On a related note, analysts at Zacks upgraded shares of WebMD Health Corp. from a neutral rating to an outperform rating in a research note to investors on Tuesday, January 21st. They now have a $52.40 price target on the stock. Finally, analysts at Stifel Nicolaus raised their price target on shares of WebMD Health Corp. from $50.00 to $55.00 in a research note to investors on Tuesday, January 21st. They now have a buy rating on the stock. One investment analyst has rated the stock with a sell rating, one has given a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of Buy and an average price target of $50.80.

WebMD Health Corp. (NASDAQ:WBMD) traded up 0.79% on Monday, hitting $47.10. The stock had a trading volume of 824,821 shares. WebMD Health Corp. has a 52 week low of $16.11 and a 52 week high of $50.56. The stock has a 50-day moving average of $44.73 and a 200-day moving average of $36.44. The company’s market cap is $2.117 billion.

WebMD Health Corp. is a provider of health information services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals, mobile platforms and health-focused publications.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.